Clare Davies qualified in 1998 with a Bachelor of Medical Science (B.Med.Sc) from the University of Birmingham and continued her studies in Birmingham obtaining a Ph.D. in Cancer Biology at the School of Cancer Sciences.
Clare was then awarded a CRUK Post-Doctoral Fellowship to work with Dr. Axel Behrens at the CRUK-London Research Institute (LRI) investigating novel mechanisms of gene expression in cancer. It was here that she first encountered arginine methylation and realized that there was still much to be discovered about this protein modification. She then joined Dr. Cathy Tournier’s lab at the University of Manchester where she built on her expertise studying cancer development in vivo using genetically altered mice.
In October 2012, Clare was awarded a Birmingham Fellowship to join the Institute of Cancer and Genomic Sciences and initiate her own research group investigating the role of arginine methylation in cancer pathogenesis. She has since been awarded an MRC New Investigator Award and a CRUK Programme Foundation Award to continue her research.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)